Allied Market Research

2024

Cancer Ivd Market

Cancer IVD Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by TECHNIQUE, by CANCER TYPE and by END USER : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cancer IVD Market Report Highlights

Aspects Details
icon_5
By Product Type
  • Reagents
  • Instruments
  • Software and Services
icon_6
By TECHNIQUE
  • Blood Testing
  • Tissue Diagnostics
icon_7
By CANCER TYPE
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer Types
icon_8
By END USER
  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Other End User
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_10
Key Market Players

GlaxoSmithKline, Roche Diagnostics, Siemens Healthineers, Illumina, Inc., Agilent Technologies, Qiagen NV, Hologic, Inc., Olympus Corporation, Thermo Fisher Scientific, Abbott Laboratories

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Cancer IVD Market

Global Opportunity Analysis and Industry Forecast, 2023-2032